IL27 and influenza: Following influenza infection, mice treated with anti-IL-27 antibodies had significantly enhanced pulmonary clearance upon secondary pneumococcal challenge (Fig 3H) and significantly increased survival rates (Fig 3I) when compared with IgG-treated mice, which were consistent with those observed in IL-27R-deficent mice.